PharVision Advisers’s Goodyear GT Stock Holding History

PharVision Advisers’s Portfolio GT Stock Details GT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,235	Closed	-$127K	–	716
2025 Q2	$127K	Buy	+12,235	New	+$130K	0.18%	241

Other funds holding GT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return

PharVision Advisers's GT Position: Q3 2025 in Review

PharVision Advisers sold out of Goodyear (GT) in Q3 2025, closing a stake of 12,235 shares — an estimated $127K sold.

PharVision Advisers first reported a position in GT in Q2 2025 and held it in 1 quarter. The position peaked at $127K in Q2 2025. 398 funds tracked by Wall St. Rank hold GT as of Q3 2025.

PharVision Advisers reported no remaining Goodyear position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 12,235 Goodyear shares in Q3 2025, an estimated $127K.
PharVision Advisers first reported a position in Goodyear in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Goodyear position peaked at $127K in Q2 2025.
398 funds tracked by Wall St. Rank held Goodyear as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.